TGen & Pancreatic Cancer Research
Pancreatic Cancer is a vicious killer, the fourth leading cause of cancer death in the US, claiming a higher percentage of lives than any other form of cancer. Dr. Daniel Von Hoff leads the Clinical Translational Research Division at TGen which focuses on genetic and biochemical approaches to identify diagnostics and molecular targets for the development of new therapies for pancreatic cancer. Dr. Von Hoff and his team were instrumental in the development of an anti-cancer agent (gemcitabine …
Related Posts
- Counting On It: New Hope from the Cancer Research Institute, by Alex Witt, MSNBC TV News Anchor
- Ovarian Cancer Research Fund with Kelly Ripa & Electrolux
- Hope - Cancer Research UK
- Fluoride and The Pineal Gland
- Tabula Rasa by Arvo Part - Radio Toast for Cancer Research
- National Cancer Research Institute: Activities
